Citryll Completes First Closing of a € 15M Series A to Develop its NETosis Inhibiting Antibody

 

Citryll Completes First Closing of a € 15M Series A to Develop its NETosis Inhibiting Antibody

The founding partners Mariette van der Velden and Han de Groot both have extensive experience in investing, entrepreneurship and managing companies across the full life cycle from startup to (public) …

More Citryll Completes First Closing of a € 15M Series A to Develop its NETosis Inhibiting Antibody Videos

Leave a Reply